These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 10213222)
1. Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse. Ritland SR; Leighton JA; Hirsch RE; Morrow JD; Weaver AL; Gendler SJ Clin Cancer Res; 1999 Apr; 5(4):855-63. PubMed ID: 10213222 [TBL] [Abstract][Full Text] [Related]
2. Multitargeted low-dose GLAD combination chemoprevention: a novel and promising approach to combat colon carcinogenesis. Mohammed A; Janakiram NB; Brewer M; Vedala K; Steele VE; Rao CV Neoplasia; 2013 May; 15(5):481-90. PubMed ID: 23633920 [TBL] [Abstract][Full Text] [Related]
3. Chemopreventive effects of RXR-selective rexinoid bexarotene on intestinal neoplasia of Apc(Min/+) mice. Janakiram NB; Mohammed A; Qian L; Choi CI; Steele VE; Rao CV Neoplasia; 2012 Feb; 14(2):159-68. PubMed ID: 22431924 [TBL] [Abstract][Full Text] [Related]
4. Piroxicam and acarbose as chemopreventive agents for spontaneous intestinal adenomas in APC gene 1309 knockout mice. Quesada CF; Kimata H; Mori M; Nishimura M; Tsuneyoshi T; Baba S Jpn J Cancer Res; 1998 Apr; 89(4):392-6. PubMed ID: 9617344 [TBL] [Abstract][Full Text] [Related]
5. Oral administration of TRAIL-inducing small molecule ONC201/TIC10 prevents intestinal polyposis in the Madka V; De La Cruz A; Pathuri G; Panneerselvam J; Zhang Y; Stratton N; Hacking S; Finnberg NK; Safran HP; Sei S; Glaze ER; Shoemaker R; Fox JT; Raufi AG; El-Deiry WS; Rao CV Am J Cancer Res; 2022; 12(5):2118-2131. PubMed ID: 35693092 [TBL] [Abstract][Full Text] [Related]
6. The chemopreventive efficacies of nonsteroidal anti-inflammatory drugs: the relationship of short-term biomarkers to long-term skin tumor outcome. Mikulec CD; Rundhaug JE; Simper MS; Lubet RA; Fischer SM Cancer Prev Res (Phila); 2013 Jul; 6(7):675-85. PubMed ID: 23682071 [TBL] [Abstract][Full Text] [Related]
7. Mucoadhesive Mesalamine Prodrug Nanoassemblies to Target Intestinal Macrophages for the Treatment of Inflammatory Bowel Disease. Park B; Han G; Jin DY; Gil KC; Shin D; Lee J; Park JY; Jang H; Park D; Lee S; Kim K; Yang Y; Kim Y; Kim JS; Kim SH; Shim MK ACS Nano; 2024 Jun; 18(25):16297-16311. PubMed ID: 38867457 [TBL] [Abstract][Full Text] [Related]
9. Preclinical colorectal cancer chemopreventive efficacy and p53-modulating activity of 3',4',5'-trimethoxyflavonol, a quercetin analogue. Howells LM; Britton RG; Mazzoletti M; Greaves P; Broggini M; Brown K; Steward WP; Gescher AJ; Sale S Cancer Prev Res (Phila); 2010 Aug; 3(8):929-39. PubMed ID: 20628003 [TBL] [Abstract][Full Text] [Related]
10. Yogurt Prevents Colorectal Tumorigenesis in Apc Li X; Qian J; Liu Q; Guo M; Zhang H; Li H; Chen W Mol Nutr Food Res; 2024 May; 68(10):e2300737. PubMed ID: 38700077 [TBL] [Abstract][Full Text] [Related]
12. A novel immunochemotherapy based on targeting of cyclooxygenase and induction of immunogenic cell death. Huang H; Huang Y; Chen Y; Luo Z; Zhang Z; Sun R; Wan Z; Sun J; Lu B; Zhang L; Hu J; Li S Biomaterials; 2021 Mar; 270():120708. PubMed ID: 33578254 [TBL] [Abstract][Full Text] [Related]
13. The Radical Scavenger NZ-419 Suppresses Intestinal Polyp Development in Kurokawa Y; Fujii G; Tomono S; Miyamoto S; Hamoya T; Takahashi M; Narita T; Komiya M; Kobayashi M; Higami Y; Mutoh M J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31963747 [TBL] [Abstract][Full Text] [Related]
14. Chemopreventive effects of 5-amino salicylic acids on inflammatory bowel disease-associated colonic cancer and colonic dysplasia: a meta-analysis. Xu X; Xu X; Ciren Y; Feng B; Tao C; Xia Y; Liu Z Int J Clin Exp Med; 2015; 8(2):2212-8. PubMed ID: 25932153 [TBL] [Abstract][Full Text] [Related]
15. Ulcerative colitis with inflammatory polyposis in a teenage boy: a case report. Feng JS; Ye Y; Guo CC; Luo BT; Zheng XB World J Gastroenterol; 2015 Jan; 21(3):1044-8. PubMed ID: 25624746 [TBL] [Abstract][Full Text] [Related]
16. Mesalamine modulates intercellular adhesion through inhibition of p-21 activated kinase-1. Khare V; Lyakhovich A; Dammann K; Lang M; Borgmann M; Tichy B; Pospisilova S; Luciani G; Campregher C; Evstatiev R; Pflueger M; Hundsberger H; Gasche C Biochem Pharmacol; 2013 Jan; 85(2):234-44. PubMed ID: 23146664 [TBL] [Abstract][Full Text] [Related]
17. Mesalamine inhibits epithelial beta-catenin activation in chronic ulcerative colitis. Brown JB; Lee G; Managlia E; Grimm GR; Dirisina R; Goretsky T; Cheresh P; Blatner NR; Khazaie K; Yang GY; Li L; Barrett TA Gastroenterology; 2010 Feb; 138(2):595-605, 605.e1-3. PubMed ID: 19879273 [TBL] [Abstract][Full Text] [Related]
18. 5-aminosalicylic acid is an attractive candidate agent for chemoprevention of colon cancer in patients with inflammatory bowel disease. Cheng Y; Desreumaux P World J Gastroenterol; 2005 Jan; 11(3):309-14. PubMed ID: 15637733 [TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer. Yao M; Lam EC; Kelly CR; Zhou W; Wolfe MM Br J Cancer; 2004 Feb; 90(3):712-9. PubMed ID: 14760389 [TBL] [Abstract][Full Text] [Related]
20. Point: From animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system. Corpet DE; Pierre F Cancer Epidemiol Biomarkers Prev; 2003 May; 12(5):391-400. PubMed ID: 12750232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]